News

ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces First Quarter 2025 Financial Results
First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...
ProMIS Neurosciences Announces First Quarter 2025 Financial Results
First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer’s Disease Six Month Interim Results Expected in 1H ...
Lowell's First Look on MSN5h
Hospice Helps ALS Patients Live Life to the Fullest
Each month, we bring you an article from Emmanuel Hospice, which has been recognized as one of the Best and Brightest ...
AB Science reports its revenues for the year 2024 and provides an update on its activities
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros ...
MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)
MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS) ...
Pro Football Network on MSN14h
Aaron Judge Inches Closer to Lou Gehrig on Yankees’ Elite List as MLB Dominance Reaches Historic Levels
New York Yankees superstar Aaron Judge is already a New York legend in his own right—but now, he’s inching closer to another ...